Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0B3E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,789
Award facts
- Contract value 100% obligated
- $30,789.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $30.8K to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on February 4, 2026, with an ultimate completion date of February 5, 2026. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating open competition. Performance will take place at AmerisourceBergen Drug Corp's corporate office in Conshohocken, Pennsylvania. This delivery order is executed as a child contract under the company's parent organization, Cencora, Inc. (doing business as AmerisourceBergen), which serves as the prime contractor.
This award is a task order issued under Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9M through December 31, 2031. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The pharmaceutical supply supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's established role as a critical federal medical procurement vendor demonstrates capability to meet DLA's requirements for essential pharmaceuticals across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F0B3E?
SPE2DR26F0B3E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F0B3E worth?
The government has obligated $30,789 on SPE2DR26F0B3E.
Is contract SPE2DR26F0B3E an order under another contract?
Yes. SPE2DR26F0B3E is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0B3E competed?
The extent of competition for SPE2DR26F0B3E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award